Timed flat infusion of 5-fluorouracil increases the tolerability of 5-fluorouracil/docetaxel regimen in metastatic breast cancer: a dose-finding study-Reference-Cited by-同舟云学术

Timed flat infusion of 5-fluorouracil increases the tolerability of 5-fluorouracil/docetaxel regimen in metastatic breast cancer: a dose-finding study

Published:2004-08 Issue:4 Volume:91 Page:618-620
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Ficorella C,Morelli M F,Ricevuto E,Cannita K,Porzio G,Baldi P Lanfiuti,Cianci G,Rocco ZC Di,Natoli C,Tinari N,Galitiis F De,Calista F,Marchetti P

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/6601971.pdf

Reference8 articles.

1. Ando M, Watanabe T, Sasaki Y, Ying DF, Omuro Y, Katsumata N, Narabayashi M, Tokue Y, Fujii H, Igarashi T, Wakita H, Ohtsu T, Itoh K, Adachi I, Taguchi T (1998) A phase I/II study of docetaxel in combination with 5-fluorouracil for advanced or recurrent breast cancer. Br J Cancer 77: 1937–1943

2. Caussanel JP, Levi F, Brienza S, Misset JL, Itzhaki M, Adam R, Milano G, Hecquet B, Mathe G (1990) Phase I trial of 5-day continuous venous infusion at circadian rhythm modulated rate compared with constant rate. J Natl Cancer Inst 82: 705–714

3. Lévi F (1997) Chronopharmacology of anticancer gents. In Handbook of Exeperimental Pharmacology: Physiology and Pharmacology of Biological Rhythms-cancer Chemotherapy, Redfern PH, Lemmer B (eds) pp 299–301, Berlin: Springer-Verlag

4. Lortholary A, Delozier T, Monnier A, Bourgeois H, Bougnoux P, Tubiana-Mathieu N, Riffaud JCh, Besson D, Lotz V, Gamelin E (2003) Phase II multicentre study of docetaxel plus 5-fluorouracil in patietnts with anthracycline-pretreated metastatic breast cancer. Br J Cancer 88: 1669–1674

5. Lortholary A, Maillard P, Delva R, Boisdron-Celle M, Perard D, Vernillet L, Besenval M, Gamelin E (2000) Docetaxel in combination with 5-fluorouracil in patients with metastatic breast cancer previously treated with anthracycline-based chemotherapy: a phase I, dose-finding study. Eur J Cancer 36: 1773–1780

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. "Poker" association of weekly alternating 5-fluorouracil, irinotecan, bevacizumab and oxaliplatin (FIr-B/FOx) in first line treatment of metastatic colorectal cancer: a phase II study;BMC Cancer;2010-10-19

2. Triplet schedule of weekly 5-Fluorouracil and alternating irinotecan or oxaliplatin in advanced colorectal cancer: A dose-finding and phase II study;Oncology Reports;2010-04-23

3. Timed-Flat Infusion of 5-Fluorouracil Associated with Docetaxel as First-Line Treatment of Patients with Metastatic Breast Cancer;The Breast Journal;2008-01